We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pro-Inflammatory Activation Suppresses TRAIL-induced Apoptosis of Acute Myeloid Leukemia Cells.
- Authors
Kobyakova, Margarita I.; Senotov, Anatoly S.; Krasnov, Kirill S.; Lomovskaya, Yana V.; Odinokova, Irina V.; Kolotova, Anastasia A.; Ermakov, Artem M.; Zvyagina, Alena I.; Fadeeva, Irina S.; Fetisova, Elena I.; Akatov, Vladimir S.; Fadeev, Roman S.
- Abstract
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) is a promising agent for treatment of AML due to its specific apoptosis-inducing effect on tumor cells but not normal cells. However, emergence of resistance to TRAIL in the AML cells limits its potential as an antileukemic agent. Previously, we revealed increase in the resistance of the human AML THP-1 cells to the TRAIL-induced death during their LPS-dependent proinflammatory activation and in the in vitro model of LPS-independent proinflammatory activation – in a long-term high-density cell culture. In this study, we investigated mechanisms of this phenomenon using Western blot analysis, caspase 3 enzymatic activity analysis, quantitative reverse transcription-PCR, and flow cytometry. The results showed that the increased resistance to the TRAIL-induced cell death of AML THP-1 cells during their pro-inflammatory activation is associated with the decrease in the surface expression of the proapoptotic receptors TRAIL-R1/DR4 and TRAIL-R2/DR5, as well as with the increased content of members of the IAPs family – Livin and cIAP2. The results of this article open up new insights into the role of inflammation in formation of the resistance of AML cells to the action of mediators of antitumor immunity, in particular TRAIL.
- Subjects
MYELOID cells; ACUTE myeloid leukemia; TRAIL protein; CELL death; APOPTOSIS; CELL culture
- Publication
Biochemistry (00062979), 2024, Vol 89, Issue 3, p431
- ISSN
0006-2979
- Publication type
Article
- DOI
10.1134/S0006297924030040